Literature DB >> 7810075

Role of androgens in prostatic cancer.

J T Isaacs1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7810075     DOI： 10.1016/s0083-6729(08)61152-8

Source DB:  PubMed          Journal:  Vitam Horm        ISSN： 0083-6729            Impact factor:   3.421


× No keyword cloud information.
  29 in total

1.  AKT-independent protection of prostate cancer cells from apoptosis mediated through complex formation between the androgen receptor and FKHR.

Authors:  Pengfei Li; Heehyoung Lee; Shaodong Guo; Terry G Unterman; Guido Jenster; Wenlong Bai
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

2.  Identification of two novel cis-elements in the promoter of the prostate-specific antigen gene that are required to enhance androgen receptor-mediated transactivation.

Authors:  J Zhang; S Zhang; P E Murtha; W Zhu; S S Hou; C Y Young
Journal:  Nucleic Acids Res       Date:  1997-08-01       Impact factor: 16.971

Review 3.  Induction of apoptosis in the prostate by alpha1-adrenoceptor antagonists: a novel effect of "old" drugs.

Authors:  N Kyprianou; S C Jacobs
Journal:  Curr Urol Rep       Date:  2000-08       Impact factor: 3.092

Review 4.  CYP17 inhibitors for prostate cancer therapy.

Authors:  Tadas S Vasaitis; Robert D Bruno; Vincent C O Njar
Journal:  J Steroid Biochem Mol Biol       Date:  2010-11-17       Impact factor: 4.292

Review 5.  Mechanisms involved in the progression of androgen-independent prostate cancers: it is not only the cancer cell's fault.

Authors:  J T Arnold; J T Isaacs
Journal:  Endocr Relat Cancer       Date:  2002-03       Impact factor: 5.678

Review 6.  Androgen action in prostate cancer.

Authors:  Sujit Basu; Donald J Tindall
Journal:  Horm Cancer       Date:  2010-10       Impact factor: 3.869

Review 7.  Molecular mechanisms of castration-resistant prostate cancer progression.

Authors:  Smitha S Dutt; Allen C Gao
Journal:  Future Oncol       Date:  2009-11       Impact factor: 3.404

8.  Alpha1-adrenergic receptors activate Ca(2+)-permeable cationic channels in prostate cancer epithelial cells.

Authors:  Stephanie Thebault; Morad Roudbaraki; Vadim Sydorenko; Yaroslav Shuba; Loic Lemonnier; Christian Slomianny; Etienne Dewailly; Jean-Louis Bonnal; Brigitte Mauroy; Roman Skryma; Natalia Prevarskaya
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

9.  Interleukin-6 regulates androgen synthesis in prostate cancer cells.

Authors:  Jae Yeon Chun; Nagalakshmi Nadiminty; Smitha Dutt; Wei Lou; Joy C Yang; Hsing-Jien Kung; Christopher P Evans; Allen C Gao
Journal:  Clin Cancer Res       Date:  2009-07-28       Impact factor: 12.531

10.  COP9 subunits 4 and 5 target soluble guanylyl cyclase α1 and p53 in prostate cancer cells.

Authors:  Meenakshi Bhansali; Lirim Shemshedini
Journal:  Mol Endocrinol       Date:  2014-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.